Minodronic acid
Minodronic acid (YM-529) is a bisphosphonate and a P2X2/3 receptor antagonist investigated for its anticancer properties, including the inhibition of cancer cell proliferation and metastasis in vitro and in vivo. It has also been extensively studied for the treatment of osteoporosis in preclinical models.
Product Specifications
CAS Number
180064-38-4
Product Name Alternative
Apoptosis, ONO 5920, ONO5920, ONO-5920, Minodronic acid, YM 529, YM529, YM-529, P2XReceptor, P2X2, P2X3, P2X Receptor, Phosphonicacid, (1-hydroxy-2-imidazo (1,2-a) pyridin-3-ylethylidene) bis-
Field of Research
Cell Biology, Neuroscience, Pharmacology & Drug Discovery
Purity
98.02% (May vary between batches)
Solubility
H2O:4 mg/mL (12.42 mM) ; DMSO:< 1 mg/mL (insoluble or slightly soluble)
Smiles
OC (Cc1cnc2ccccn12) (P (O) (O) =O) P (O) (O) =O
Molecular Formula
C9H12N2O7P2
Molecular Weight
322.15
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7012384-01 0.02 mg
Recombinant Kluyveromyces lactis Protoheme IX farnesyltransferase, mitochondrial (COX10)
Sign In for Pricing
View Details MBS7012384-02 0.1 mg
Recombinant Kluyveromyces lactis Protoheme IX farnesyltransferase, mitochondrial (COX10)
Sign In for Pricing
View Details MBS7012384-03 5x 0.1 mg
Recombinant Kluyveromyces lactis Protoheme IX farnesyltransferase, mitochondrial (COX10)
Sign In for Pricing
View Details 